Quantitative Investment Management LLC purchased a new position in shares of WebMD Health Corp (NASDAQ:WBMD) during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 16,200 shares of the health services provider’s stock, valued at approximately $950,000.

Other institutional investors have also modified their holdings of the company. Meadow Creek Investment Management LLC lifted its holdings in WebMD Health Corp by 10.0% during the first quarter. Meadow Creek Investment Management LLC now owns 1,936 shares of the health services provider’s stock worth $102,000 after acquiring an additional 176 shares during the period. Asset Management One Co. Ltd. bought a new stake in WebMD Health Corp during the first quarter worth $148,000. Bank of Montreal Can lifted its holdings in WebMD Health Corp by 7.8% during the second quarter. Bank of Montreal Can now owns 2,966 shares of the health services provider’s stock worth $174,000 after acquiring an additional 214 shares during the period. Turner Investments LLC bought a new stake in WebMD Health Corp during the second quarter worth $176,000. Finally, Envestnet Asset Management Inc. lifted its holdings in WebMD Health Corp by 39.6% during the first quarter. Envestnet Asset Management Inc. now owns 3,364 shares of the health services provider’s stock worth $178,000 after acquiring an additional 954 shares during the period. Institutional investors and hedge funds own 90.99% of the company’s stock.

WBMD has been the subject of a number of recent research reports. Zacks Investment Research raised WebMD Health Corp from a “hold” rating to a “buy” rating and set a $62.00 target price for the company in a research report on Tuesday, July 18th. BidaskClub raised WebMD Health Corp from a “strong sell” rating to a “sell” rating in a research report on Friday, June 23rd. SunTrust Banks, Inc. downgraded WebMD Health Corp from a “buy” rating to a “hold” rating and raised their target price for the stock from $60.00 to $66.50 in a research report on Tuesday, July 25th. Finally, Raymond James Financial, Inc. downgraded WebMD Health Corp from an “outperform” rating to a “mkt perform” rating in a research report on Wednesday, July 26th. One analyst has rated the stock with a sell rating, six have issued a hold rating and three have assigned a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus target price of $65.25.

COPYRIGHT VIOLATION NOTICE: “Quantitative Investment Management LLC Purchases Shares of 16,200 WebMD Health Corp (WBMD)” was reported by Watch List News and is owned by of Watch List News. If you are viewing this piece on another website, it was stolen and reposted in violation of US and international copyright laws. The correct version of this piece can be accessed at https://www.watchlistnews.com/quantitative-investment-management-llc-purchases-shares-of-16200-webmd-health-corp-wbmd/1600487.html.

WebMD Health Corp (NASDAQ:WBMD) opened at 66.48 on Friday. The stock has a market capitalization of $2.43 billion, a PE ratio of 34.04 and a beta of 0.79. WebMD Health Corp has a 52-week low of $48.10 and a 52-week high of $66.57. The company’s 50-day moving average price is $66.35 and its 200 day moving average price is $58.11.

About WebMD Health Corp

WebMD Health Corp. is a provider of health information services. The Company provides its services to consumers, physicians and other healthcare professionals through its Websites, mobile applications and health-focused publications. Advertisers and sponsors use The WebMD Health Network to reach and engage healthcare professionals and consumers who are interested in healthy living, wellness, diseases and conditions, and other health-related topics.

Institutional Ownership by Quarter for WebMD Health Corp (NASDAQ:WBMD)

Receive News & Ratings for WebMD Health Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WebMD Health Corp and related companies with Analyst Ratings Network's FREE daily email newsletter.